Clinical trail of NRL/2019/NL in Liver Disorder Patients with Abnormal Liver Function Test
- Conditions
- Health Condition 1: K769- Liver disease, unspecified
- Registration Number
- CTRI/2020/01/023033
- Lead Sponsor
- etsurf Communications Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Males or females 18-65 years of age
Diagnosis of hepatic disorder with abnormal LFT with or without signs and symptoms such as dark-colored urine, light-colored stools, pruritus, pruritic red hives, fever, nausea, vomiting, anorexia, and right upper abdominal discomfort, pain
Subjects with or without fatty liver changes observed in Ultrasonography of abdomen will be enrolled in the study
Serum total bilirubin level less than or equal to 2 mg/dl, or AST or ALT 2 times than normal values
Subjects willing to sign inform consent form
Evidence of chronic viral hepatitis (Hepatitis B or C) and Biliary obstruction
Previous entry into the study, or use of either prednisolone or PTX within 6 weeks of admission
AST >500 U/L or ALT >300 U/L
Suspected hypersensitivity to contents of study drug
Advanced liver disease, subjects with serious illness
History of gastritis, peptic ulcer, bleeding ulcer
Patients with a renal failure
Pregnant or lactating women
Other conditions, which in the opinion of the investigators, makes the patient unsuitable for enrollment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method